Ingram Micro (INGM) 2025 Net Sales Grow 9.5% to $52.6B on Record Q4 Performance
Ingram Micro Holding Corporation (NYSE:INGM) is one of the cheap new stocks to buy now. On March 2, Ingram Micro Holding Corporation reported financial results for 2025, with net sales reaching $52.6 billion, which was a 9.5% increase year-over-year. Q4 was particularly strong, generating $14.9 billion in net sales and surpassing the high end of the company’s guidance. This growth was distributed across all four geographic segments, with the Asia-Pacific region delivering consistent double-digit gains.
Despite a shift in sales mix toward lower-margin AI-enablement and client solutions, the company improved its operational efficiency, reducing full year operating expenses to 5% of net sales. Furthermore, Q4 adjusted free cash flow reached $1.63 billion, marking the highest quarterly level for the company in over a decade. The CEO attributed much of this momentum to the Xvantage platform, which now processes the majority of the company’s net sales and utilizes AI-driven capabilities to enhance customer productivity.
For Q1 2026, Ingram Micro Holding Corporation (NYSE:INGM) projects net sales between $12.45 billion and $12.80 billion. The company expects continued expansion in operating expense leverage and improving gross margins, forecasting non-GAAP diluted EPS in the range of $0.67 to $0.75. This outlook reflects a potential year-over-year earnings increase of up to 23%.
Ingram Micro Holding Corporation (NYSE:INGM), through its subsidiaries, distributes information technology products, cloud, and other services in North America, Europe, the Middle East, Africa, the Asia-Pacific, Latin America, and internationally.
While we acknowledge the potential of INGM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the
Disclosure: None.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why Lam Research (LRCX) Stock Is Falling Today

Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
Why Bloom Energy (BE) Shares Are Falling Today

ArriVent BioPharma Reports Full Year 2025 Financial Results

